Characterization of producer cell-dependent restriction of murine leukemia virus replication

Journal of Virology

Volumn 76, Issue 13, 2002, Pages 6609-6617

  Serhan, Fatima ^a   Jourdan, Nathalie ^a   Saleun, Sylvie ^a   Moullier, Philippe ^a   Duisit, Ghislaine ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA; THROMBOSPONDIN; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL SPECIFICITY; CONTROLLED STUDY; ENDOCYTOSIS; FIBROSARCOMA; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; LUNG CARCINOMA; MURINE LEUKEMIA; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL; VESICULAR STOMATITIS VIRUS; VIRION; VIRUS ADSORPTION; VIRUS CARCINOGENESIS; VIRUS CORE; VIRUS DNA CELL DNA INTERACTION; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN;

3T3 CELLS; ANIMALS; DEFECTIVE VIRUSES; GENE PRODUCTS, ENV; HUMANS; LEUKEMIA VIRUS, MURINE; MEMBRANE GLYCOPROTEINS; MICE; RATS; TUMOR CELLS, CULTURED; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS ASSEMBLY; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 0036278425     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.13.6609-6617.2002     Document Type: Article

References (75)

1. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A
2. Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions
3. Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: Functional difference between Vif and Nef
4. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins
5. Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells
6. A membraneproximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor
7. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton
8. Human immunodeficiency virus matrix tyrosine phosphorylation: Characterization of the kinase and its substrate requirements
9. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity
10. Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection
11. Fv-1 host cell restriction of Friend leukemia virus: Microinjection of unintegrated viral DNA
12. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene
13. Retroviridae: The viruses and their replication
14. High-titer packaging cells producing recombinant retroviruses resistant to human serum
15. Mutations in Gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection
16. Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell viral transmission
17. Baculovirus vector requires electrostatic interactions including heparan sulfate for efficient gene transfer in mammalian cells
18. Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines
19. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1
20. Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus
21. + T lymphocytes
22. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator
23. WW domains and retrovirus budding
24. Role of Vif in human immunodeficiency virus type 1 reverse transcription
25. Both the structure and DNA binding function of the barrier-to-autointegration factor contribute to reconstitution of HIV type 1 integration in vitro
26. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein
27. A simplified system for generating recombinant adenoviruses
28. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease
29. Gene therapy of metastatic cancer by in vivo retroviral gene targeting
30. Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway
31. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle
32. Use of helper-free replication-defective simian immunodeficiency virus-based vectors to study macrophage and T tropism: Evidence for distinct levels of restriction in primary macrophages and a T-cell line
33. Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion
34. A previously unidentified host protein protects retroviral DNA from autointegration
35. Modulation of activity of Moloney murine leukemia virus preintegration complexes by host factors in vitro
36. Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin
37. Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: Implications for HIV-based gene transfer systems
38. Cellular and viral specificities of human immunodeficiency virus type 1 Vif protein
39. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1
40. A block to human immunodeficiency virus type 1 assembly in murine cells
41. Characterization of a late entry event in the replication cycle of human immunodeficiency virus type 2
42. The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages
43. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein
44. The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: Evidence for a role in genomic RNA encapsidation
45. RNA trafficking signals in human immunodeficiency virus type 1
46. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions
47. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions
48. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins
49. Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein
50. A cell-line-specific defect in the intracellular transport and release of assembled retroviral capsids
51. Ubiquitin is part of the retrovirus budding machinery
52. Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro
53. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein
54. HIV-1 Gag protein associates with F-actin present in microfilaments
55. Factors influencing recombinant adeno-associated virus production
56. Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions
57. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: Replication is restricted at a postentry level
58. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2
59. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell
60. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes
61. A role for ubiquitin ligase recruitment in retrovirus release
62. Structure and function of the WW domain
63. Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain
64. Characterization of a novel protein-binding module-the WW domain
65. Cellular motor protein KIF-4 associates with retroviral Gag
66. A conserved mechanism of retrovirus restriction in mammals
67. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: Interference with early steps of viral replication
68. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag)
69. Ubiquitin in retrovirus assembly: Actor or bystander?
70. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
71. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain
72. A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release
73. The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle
74. Mutations altering the Moloney murine leukemia virus p12 gag protein affect virion production and early events of the virus life cycle
75. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo